Dr. Khaled Dibs | Reirradiation | Best Researcher Award 

Dr. Khaled Dibs | Reirradiation | Physician at The Ohio State University Wexner Medical Center | United States

Dr. Khaled Dibs is a distinguished physician and researcher at The Ohio State University Wexner Medical Center, with a primary focus on radiation oncology and reirradiation. His career is marked by a dedication to advancing clinical practices, improving patient outcomes, and contributing to the scientific understanding of cancer treatment. With an active role at The Ohio State University Comprehensive Cancer Center, Dr. Dibs combines clinical expertise with academic leadership, making significant strides in translational oncology research. His reputation is built on high-quality publications, consistent scholarly impact, and collaborative research efforts that enhance the global understanding of advanced radiation therapies.

Academic Profile

SCOPUS | ORCID

Education

Dr. Khaled Dibs pursued his academic journey with rigorous training in medicine and oncology, culminating in doctoral-level research in radiation oncology. His academic foundation has provided the expertise necessary to investigate complex issues within cancer therapy, particularly the challenges and opportunities of reirradiation. Throughout his education, he developed a strong grounding in evidence-based medicine, advanced radiotherapy technologies, and clinical decision-making. His academic preparation continues to inform both his clinical practice and research contributions, allowing him to integrate theory with applied innovations in oncology.

Experience

With an extensive background in clinical practice and research, Dr. Khaled Dibs has established himself as a leading physician at The Ohio State University Wexner Medical Center. His clinical work emphasizes precision in radiation oncology, focusing on patients requiring reirradiation treatments. Beyond his clinical commitments, Dr. Dibs has contributed to multiple institutional and international research projects, generating impactful findings that influence best practices. His experience also spans mentorship and academic service, where he has supported young researchers and medical trainees in advancing their careers. His involvement in multidisciplinary teams underscores his ability to bridge clinical medicine with research excellence, making him a respected figure in both domains.

Research Interest

Dr. Khaled Dibs is deeply invested in research that addresses the challenges of reirradiation, exploring both the risks and therapeutic benefits associated with repeat radiation therapies. His scholarly work emphasizes the development of predictive models for treatment outcomes, the identification of clinical risk factors, and strategies to improve patient quality of life during and after treatment. He is particularly interested in vertebral endplate disruptions, brachial plexopathy predictors, and optimizing treatment protocols for head and neck cancers. His research not only contributes to the academic community but also provides real-world improvements in patient care. His investigations are consistently published in high-impact journals and cited by peers, highlighting his influence within the oncology field.

Award

Dr. Khaled Dibs has earned recognition for his pioneering work in radiation oncology and reirradiation. His contributions to scientific knowledge and clinical practice have positioned him as a strong candidate for the Best Researcher Award in Reirradiation. This acknowledgment reflects his dedication to advancing oncology research, his publication record, and his ability to translate research into meaningful clinical improvements. The award nomination also highlights his standing as a physician-researcher who embodies both academic excellence and humanitarian commitment to patient-centered cancer care.

Selected Publications

• Expanded analysis of vertebral endplate disruption and its impact on vertebral compression fracture risk (2025, 1 citation)

• Predictors of brachial plexopathy following head and neck reirradiation (2025, 2 citations)

• Clinical outcomes of reirradiation in patients with recurrent head and neck cancer: predictive factors and management strategies (2024, 5 citations)

• Toxicity and efficacy outcomes of modern reirradiation approaches in recurrent cancer treatment (2023, 7 citations)

Conclusion

Dr. Khaled Dibs stands out as a highly accomplished researcher and physician whose dedication to reirradiation has significantly advanced the field of radiation oncology. Through his publications, clinical expertise, and collaborations, he has provided vital insights into the safety, risks, and outcomes of repeat radiation treatments. His work is widely recognized by peers, with measurable citation impact and growing influence in the global oncology research community. Dr. Dibs not only demonstrates academic leadership but also embodies the qualities of a compassionate physician dedicated to patient well-being. His career trajectory shows continued promise for groundbreaking contributions, making him a deserving candidate for the Best Researcher Award in Reirradiation.